Status:
COMPLETED
Resolution of Type 2 Diabetes Mellitus: Intensive vs. Conventional Glycaemic Control After Obesity Surgery
Lead Sponsor:
Imperial College London
Conditions:
Type 2 Diabetes Mellitus
Obesity
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Obesity surgery is very effective in improving or even curing Type 2 Diabetes in patients with obesity. Many patients stop or reduce their medication after surgery and this can happen fairly quickly. ...
Detailed Description
Subjects would be randomised into intensive glycaemic control and conventional glycaemic control after obesity surgery. Data on complications of diabetes such as eye, nerve and kidney will be collecte...
Eligibility Criteria
Inclusion
- Patients with Type 2 Diabetes Mellitus who have been approved for obesity surgery
Exclusion
- Patients with Type 2 Diabetes Mellitus who do not require insulin immediately after obesity surgery
Key Trial Info
Start Date :
December 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2016
Estimated Enrollment :
35 Patients enrolled
Trial Details
Trial ID
NCT01257087
Start Date
December 1 2010
End Date
August 1 2016
Last Update
November 13 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Imperial College Healthcare NHS Trust
London, United Kingdom, W6 8RF